Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease

  • Oh S
  • Chang M
  • Song J
  • et al.
73Citations
Citations of this article
113Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Use of the physiological mechanisms promoting midbrain DA ( mDA ) neuron survival seems an appropriate option for developing treatments for Parkinson's disease ( PD ). mDA neurons are specifically marked by expression of the transcription factors Nurr1 and Foxa2. We show herein that Nurr1 and Foxa2 interact to protect mDA neurons against various toxic insults, but their expression is lost during aging and degenerative processes. In addition to their proposed cell‐autonomous actions in mDA neurons, forced expression of these factors in neighboring glia synergistically protects degenerating mDA neurons in a paracrine mode. As a consequence of these bimodal actions, adeno‐associated virus ( AAV )‐mediated gene delivery of Nurr1 and Foxa2 in a PD mouse model markedly protected mDA neurons and motor behaviors associated with nigrostriatal DA neurotransmission. The effects of the combined gene delivery were dramatic, highly reproducible, and sustained for at least 1 year, suggesting that expression of these factors is a promising approach in PD therapy. image Gene therapy of Nurr1 and Foxa2 protects midbrain dopamine ( mDA ) neurons from degeneration in a mouse model of Parkinson's disease ( PD ), suggesting that exploitation of the physiological mechanisms promoting mDA neuron survival might be an option for developing treatments for PD. Nurr1 and Foxa2 are specifically expressed in mDA neurons of adult mouse midbrain and synergistically interact to promote neuronal survival. Nurr1 and Foxa2 protein expression is lost in mDA neurons during aging and degenerative processes. Forced expression of Nurr1 and Foxa2 protects mDA neurons from various toxic insults in vitro and in vivo , and relieved motor deficits associated with mDA neuronal loss in the PD mouse model. In addition to cell‐autonomous actions in mDA neurons, combined Nurr1+Foxa2 transgene expression in glial cells creates a neuroprotective environment by suppressing the secretion of pro‐inflammatory cytokines as well as promoting the release of neurotrophic factors.

References Powered by Scopus

Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway

3110Citations
N/AReaders
Get full text

Molecular dissection of reactive astrogliosis and glial scar formation

2088Citations
N/AReaders
Get full text

RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides

1700Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments

374Citations
N/AReaders
Get full text

Adeno-Associated Virus-Based Gene Therapy for CNS Diseases

222Citations
N/AReaders
Get full text

Nurr1-Based Therapies for Parkinson's Disease

94Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Oh, S., Chang, M., Song, J., Rhee, Y., Joe, E., Lee, H., … Lee, S. (2015). Combined Nurr1 and Foxa2 roles in the therapy of Parkinson’s disease. EMBO Molecular Medicine, 7(5), 510–525. https://doi.org/10.15252/emmm.201404610

Readers over time

‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2505101520

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 46

61%

Researcher 25

33%

Professor / Associate Prof. 5

7%

Readers' Discipline

Tooltip

Neuroscience 30

38%

Agricultural and Biological Sciences 25

31%

Biochemistry, Genetics and Molecular Bi... 13

16%

Medicine and Dentistry 12

15%

Save time finding and organizing research with Mendeley

Sign up for free
0